Sarcoma  >>  VG161  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VG161 / ViroGin Biotech
NCT06126510: Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

Recruiting
2
40
RoW
Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell), VG161
CNBG-Virogin Biotech (Shanghai) Ltd.
Sarcoma
07/25
01/26

Download Options